Stock Analysis on Net

HCA Healthcare Inc. (NYSE:HCA)

This company has been moved to the archive! The financial data has not been updated since May 3, 2022.

Common Stock Valuation Ratios (Price Multiples) 
Quarterly Data

Microsoft Excel

Historical Valuation Ratios (Summary)

HCA Healthcare Inc., historical price multiples (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Price to earnings (P/E) 9.39 10.65 11.89 16.18 14.47 16.06 12.48 12.95 11.02 14.30 12.96 11.89 11.68 12.84 14.56 15.73 12.60 15.92
Price to operating profit (P/OP) 5.72 6.56 7.23 9.33 8.24 8.31 6.21 6.07 4.90 6.93 6.35 6.18 6.13 6.88 6.71 6.76 5.19 5.82
Price to sales (P/S) 1.07 1.26 1.35 1.43 1.26 1.17 0.84 0.86 0.65 0.98 0.91 0.89 0.90 1.04 1.01 1.00 0.77 0.81
Price to book value (P/BV) 269.16 105.40

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. HCA Healthcare Inc. P/E ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. HCA Healthcare Inc. P/OP ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. HCA Healthcare Inc. P/S ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.

Price to Earnings (P/E)

HCA Healthcare Inc., historical P/E calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
No. shares of common stock outstanding1 295,484,400 303,600,000 311,022,800 320,141,900 330,655,500 339,917,500 338,374,700 338,033,300 337,618,900 338,427,300 339,178,300 340,982,800 342,307,400 342,376,700 344,160,500 346,046,000 349,299,200 349,903,700 354,052,500 361,249,700 366,904,600
Selected Financial Data (US$)
Net income attributable to HCA Healthcare, Inc. (in millions) 1,273 1,814 2,269 1,450 1,423 1,426 668 1,079 581 1,071 612 783 1,039 1,064 759 820 1,144 474 426 657 659
Earnings per share (EPS)2 23.03 22.91 21.12 15.51 13.90 11.04 10.05 9.89 9.02 10.36 10.31 10.69 10.76 11.06 9.29 8.28 7.73 6.33 0.00 0.00 0.00
Share price1, 3 216.30 244.10 250.99 251.00 201.06 177.37 125.40 128.05 99.48 148.11 133.65 127.14 125.61 142.01 135.24 130.16 97.40 100.84 77.92 78.87 84.13
Valuation Ratio
P/E ratio4 9.39 10.65 11.89 16.18 14.47 16.06 12.48 12.95 11.02 14.30 12.96 11.89 11.68 12.84 14.56 15.73 12.60 15.92
Benchmarks
P/E Ratio, Competitors5
Abbott Laboratories 25.48 29.13 31.42 33.80 36.79 48.49 58.45 58.36 45.61 41.83
Cigna Group 15.72 13.43 8.43 8.60 10.62 8.71 14.60 12.08 13.82 13.26
CVS Health Corp. 16.49 17.39 16.78 14.94 14.44 12.88 10.69 10.20 10.94 14.15
Elevance Health Inc. 20.46 18.13 18.65 22.10 19.99 15.87 14.35 11.97 14.80 15.96
Humana Inc. 18.48 18.34 22.09 22.82 15.20 14.48 13.49 15.26 19.09 18.10
Intuitive Surgical Inc. 55.10 59.94 71.86 69.15 89.95 87.47 82.17 70.73 44.27 48.72
Medtronic PLC 46.71 46.56 55.13 42.80 32.34 26.30 25.38 31.86 32.75 28.78
UnitedHealth Group Inc. 27.29 26.03 27.92 27.41 23.06 20.54 17.70 16.88 19.91 20.48

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Data adjusted for splits and stock dividends.

2 Q1 2022 Calculation
EPS = (Net income attributable to HCA Healthcare, Inc.Q1 2022 + Net income attributable to HCA Healthcare, Inc.Q4 2021 + Net income attributable to HCA Healthcare, Inc.Q3 2021 + Net income attributable to HCA Healthcare, Inc.Q2 2021) ÷ No. shares of common stock outstanding
= (1,273,000,000 + 1,814,000,000 + 2,269,000,000 + 1,450,000,000) ÷ 295,484,400 = 23.03

3 Closing price as at the filing date of HCA Healthcare Inc. Quarterly or Annual Report.

4 Q1 2022 Calculation
P/E ratio = Share price ÷ EPS
= 216.30 ÷ 23.03 = 9.39

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. HCA Healthcare Inc. P/E ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.

Price to Operating Profit (P/OP)

HCA Healthcare Inc., historical P/OP calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
No. shares of common stock outstanding1 295,484,400 303,600,000 311,022,800 320,141,900 330,655,500 339,917,500 338,374,700 338,033,300 337,618,900 338,427,300 339,178,300 340,982,800 342,307,400 342,376,700 344,160,500 346,046,000 349,299,200 349,903,700 354,052,500 361,249,700 366,904,600
Selected Financial Data (US$)
Operating income (in millions) 2,211 2,949 3,520 2,493 2,336 2,449 1,333 1,947 1,526 2,025 1,634 1,667 1,910 1,931 1,511 1,667 1,961 1,801 1,231 1,558 1,475
Operating profit per share2 37.81 37.21 34.72 26.90 24.39 21.34 20.19 21.10 20.30 21.38 21.06 20.58 20.50 20.65 20.17 19.25 18.75 17.33 0.00 0.00 0.00
Share price1, 3 216.30 244.10 250.99 251.00 201.06 177.37 125.40 128.05 99.48 148.11 133.65 127.14 125.61 142.01 135.24 130.16 97.40 100.84 77.92 78.87 84.13
Valuation Ratio
P/OP ratio4 5.72 6.56 7.23 9.33 8.24 8.31 6.21 6.07 4.90 6.93 6.35 6.18 6.13 6.88 6.71 6.76 5.19 5.82
Benchmarks
P/OP Ratio, Competitors5
Abbott Laboratories 21.33 24.45 26.84 29.01 31.39 40.69 45.82 45.19 35.87 34.03
Cigna Group 10.40 9.08 9.12 9.28 11.13 9.03 9.24 7.58 8.59 8.38
CVS Health Corp. 10.06 10.43 9.43 7.87 7.61 6.65 5.89 5.98 6.19 7.83
Elevance Health Inc. 17.53 15.70 15.81 19.93 15.79 12.10 10.93 9.03 11.95 13.55
Humana Inc. 17.45 17.08 21.55 14.39 11.02 9.78 9.84 11.28 14.59 15.35
Intuitive Surgical Inc. 49.98 56.11 67.95 69.51 89.18 88.37 83.88 71.30 43.68 48.89
Medtronic PLC 38.83 37.44 49.88 42.55 35.86 26.29 21.01 23.52 22.21 21.26
UnitedHealth Group Inc. 19.69 18.77 19.63 19.05 16.12 14.12 12.35 11.85 13.80 14.40

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Data adjusted for splits and stock dividends.

2 Q1 2022 Calculation
Operating profit per share = (Operating incomeQ1 2022 + Operating incomeQ4 2021 + Operating incomeQ3 2021 + Operating incomeQ2 2021) ÷ No. shares of common stock outstanding
= (2,211,000,000 + 2,949,000,000 + 3,520,000,000 + 2,493,000,000) ÷ 295,484,400 = 37.81

3 Closing price as at the filing date of HCA Healthcare Inc. Quarterly or Annual Report.

4 Q1 2022 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 216.30 ÷ 37.81 = 5.72

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. HCA Healthcare Inc. P/OP ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.

Price to Sales (P/S)

HCA Healthcare Inc., historical P/S calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
No. shares of common stock outstanding1 295,484,400 303,600,000 311,022,800 320,141,900 330,655,500 339,917,500 338,374,700 338,033,300 337,618,900 338,427,300 339,178,300 340,982,800 342,307,400 342,376,700 344,160,500 346,046,000 349,299,200 349,903,700 354,052,500 361,249,700 366,904,600
Selected Financial Data (US$)
Revenues (in millions) 14,945 15,064 15,276 14,435 13,977 14,293 13,311 11,068 12,861 13,523 12,694 12,602 12,517 12,274 11,451 11,529 11,423 11,562 10,696 10,733 10,623
Sales per share2 202.11 193.52 186.42 174.97 159.23 151.60 150.02 148.35 153.07 151.69 147.67 143.24 139.56 136.33 133.56 130.65 127.15 124.65 0.00 0.00 0.00
Share price1, 3 216.30 244.10 250.99 251.00 201.06 177.37 125.40 128.05 99.48 148.11 133.65 127.14 125.61 142.01 135.24 130.16 97.40 100.84 77.92 78.87 84.13
Valuation Ratio
P/S ratio4 1.07 1.26 1.35 1.43 1.26 1.17 0.84 0.86 0.65 0.98 0.91 0.89 0.90 1.04 1.01 1.00 0.77 0.81
Benchmarks
P/S Ratio, Competitors5
Abbott Laboratories 4.42 4.78 5.38 5.36 5.64 6.30 6.13 5.77 5.09 4.83
Cigna Group 0.48 0.42 0.42 0.42 0.55 0.46 0.50 0.41 0.45 0.44
CVS Health Corp. 0.44 0.47 0.45 0.39 0.40 0.35 0.32 0.32 0.30 0.37
Elevance Health Inc. 0.89 0.81 0.78 0.73 0.76 0.60 0.61 0.63 0.65 0.74
Humana Inc. 0.65 0.65 0.73 0.71 0.73 0.64 0.76 0.76 0.74 0.76
Intuitive Surgical Inc. 15.34 17.89 22.12 21.73 23.19 21.29 20.09 18.44 13.33 15.01
Medtronic PLC 5.74 5.57 5.71 5.43 5.11 4.36 4.34 4.82 4.72 4.36
UnitedHealth Group Inc. 1.61 1.58 1.55 1.47 1.49 1.24 1.18 1.17 1.12 1.18

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Data adjusted for splits and stock dividends.

2 Q1 2022 Calculation
Sales per share = (RevenuesQ1 2022 + RevenuesQ4 2021 + RevenuesQ3 2021 + RevenuesQ2 2021) ÷ No. shares of common stock outstanding
= (14,945,000,000 + 15,064,000,000 + 15,276,000,000 + 14,435,000,000) ÷ 295,484,400 = 202.11

3 Closing price as at the filing date of HCA Healthcare Inc. Quarterly or Annual Report.

4 Q1 2022 Calculation
P/S ratio = Share price ÷ Sales per share
= 216.30 ÷ 202.11 = 1.07

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. HCA Healthcare Inc. P/S ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.

Price to Book Value (P/BV)

HCA Healthcare Inc., historical P/BV calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
No. shares of common stock outstanding1 295,484,400 303,600,000 311,022,800 320,141,900 330,655,500 339,917,500 338,374,700 338,033,300 337,618,900 338,427,300 339,178,300 340,982,800 342,307,400 342,376,700 344,160,500 346,046,000 349,299,200 349,903,700 354,052,500 361,249,700 366,904,600
Selected Financial Data (US$)
Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc. (in millions) (2,033) (933) (695) (593) 247 572 (974) (1,786) (2,962) (2,808) (3,565) (3,902) (4,354) (4,950) (5,605) (5,989) (6,244) (6,806) (6,780) (6,792) (7,017)
Book value per share (BVPS)2 -6.88 -3.07 -2.23 -1.85 0.75 1.68 -2.88 -5.28 -8.77 -8.30 -10.51 -11.44 -12.72 -14.46 -16.29 -17.31 -17.88 -19.45 -19.15 -18.80 -19.12
Share price1, 3 216.30 244.10 250.99 251.00 201.06 177.37 125.40 128.05 99.48 148.11 133.65 127.14 125.61 142.01 135.24 130.16 97.40 100.84 77.92 78.87 84.13
Valuation Ratio
P/BV ratio4 269.16 105.40
Benchmarks
P/BV Ratio, Competitors5
Abbott Laboratories 5.56 5.75 6.61 6.38 6.27 6.65 6.30 5.94 5.40 4.96 4.65 4.86 4.49
Cigna Group 1.84 1.53 1.49 1.44 1.86 1.46 1.61 1.34 1.51 1.49 1.49 1.44 1.42
CVS Health Corp. 1.79 1.83 1.71 1.47 1.51 1.33 1.24 1.24 1.21 1.47 1.47 1.23 1.25
Elevance Health Inc. 3.55 3.07 2.88 2.67 2.78 2.19 2.10 2.06 2.23 2.42 2.13 2.40 2.15
Humana Inc. 3.66 3.34 3.63 3.82 3.99 3.55 3.55 3.71 4.04 4.07 3.48 3.38 3.07
Intuitive Surgical Inc. 7.48 8.59 10.64 10.35 10.40 9.53 9.35 9.19 7.22 8.13 8.43 8.49 8.68
Medtronic PLC 3.52 3.26 3.14 3.02 2.84 2.48 2.60 2.94 2.87 2.66 2.48 2.62 2.59
UnitedHealth Group Inc. 6.54 6.27 6.13 5.76 5.86 4.83 4.54 4.53 4.81 4.92 4.32 4.40 4.37

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Data adjusted for splits and stock dividends.

2 Q1 2022 Calculation
BVPS = Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc. ÷ No. shares of common stock outstanding
= -2,033,000,000 ÷ 295,484,400 = -6.88

3 Closing price as at the filing date of HCA Healthcare Inc. Quarterly or Annual Report.

4 Q1 2022 Calculation
P/BV ratio = Share price ÷ BVPS
= 216.30 ÷ -6.88 =

5 Click competitor name to see calculations.